Skip to content

Aurora Cannabis stock plunge 18% on bleak revenue outlook

Aurora Cannabis stock plunge 18% on bleak revenue outlook

Aurora Cannabis stock (NYSE: ACB) price lost 18% of value in post-market trading despite beating revenue and earnings estimates for the fourth quarter. The shares of Canadian cannabis producer sink due to lower than expected revenue outlook for the first quarter of 2021. Investors have been showing concerns over the declining trend in revenues.

Its fourth-quarter revenue of $72.11 million topped consensus estimate by $0.62 million, but revenue fell 4.5% from the past year period. Its medical cannabis revenue jumped 4% from the past year period while consumer cannabis revenue dropped 9% year over year.

ACB Aurora Cannabis Inc. daily Stock Chart
Aurora Cannabis stock performance. Finviz chart

Moreover, the company expects the declining trend to extend into the next year. It expects first-quarter revenue to stand in the range of $60 to $64 million, down from the previous quarter revenue of $72 million.

On the positive side, Aurora Cannabis has been successfully moving its business towards profitability. The company expects to generate positive EBITDA in the second quarter of 2021. Its EBITDA loss stood around $34.6 million in the fourth quarter of 2020 and $50.4 million in the third quarter.

“Our Q4 demonstrated progress in the rationalization of SG&A and cash burn along with continued leadership in both Canadian and international medical. However, Aurora has slipped from its top position in Canadian consumer, a market that continues to support material growth and opportunity,” stated Miguel Martin, Chief Executive Officer of Aurora.

It’s selling, general and administrative expenses dropped by $11.2 million to $67 million in the fourth quarter. The company plans to slash its expenses in the following quarters to improve its margins.

It has also been aggressively working on lowering the cost of production. Its cash cost to produce per gram of dried cannabis dropped to $0.89 in the fourth quarter, down sharply compared to $1.22 in the previous quarter.

Aurora Cannabis stock price is currently trading around $6, slightly above from 52-weeks low of $5 a share. Aurora Cannabis stock has lost almost 87% of value in the last twelve months.   

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.